lactulose (Kristalose®)
DrugCrystals to be dissolved in water and taken as prescribed.
Other names: Kristalose®
NCT Number: NCT00712543
This study will evaluate whether patients have an overall preference for Kristalose® or liquid lactulose based on taste, consistency, and portability.
Looking for future studies?
Notify Me18 year–70 year
All sexes
Interventional
Phase 4
Arya Gastroenterology Associates, Brooklyn, New York, United States
This study will evaluate whether patients have an overall preference for Kristalose® or liquid lactulose based on taste, consistency, and portability.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Crystals to be dissolved in water and taken as prescribed.
Other names: Kristalose®
Liquid to be taken as prescribed.
Time frame: 14 days
Looking for future studies?
Notify MeCumberland Pharmaceuticals
Industry
A Preference Study Comparing Kristalose® and Liquid Lactulose in the Treatment of Constipation
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07032376
Constipation, Pathological Conditions, Signs and Symptoms
Ann Arbor, Michigan, United States
View Trial DetailsNCT06159777
Constipation, Pathological Conditions, Anatomical
Cleveland, Ohio, United States
View Trial DetailsNCT07705542
Anismus, Ataxia
Hull, United Kingdom
View Trial DetailsNCT06298331
Constipation, Pathological Conditions, Signs and Symptoms
Ankara, Turkey (Türkiye)
View Trial Details